U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Inspections and Investigations
  5. Contact the Office of Inspections and Investigations
  6. OII Ombudsman
  1. Contact the Office of Inspections and Investigations

OII Ombudsman

An Objective Neutral Resource


Ombudsman Program was created to enhance the operations of the FDA Office of Inspections and Investigations (OII) by serving as a confidential, neutral resource to improve communication channels, resolve disputes, and foster positive relationships with internal and external stakeholders including industry, government, and the public.

The ombudsman assists stakeholders in identifying and evaluating options; explaining the appropriate process for resolution; referring concerns, when possible, to the appropriate office or program; and monitoring outcomes. Stakeholders can request ombudsman assistance with issues involving:

  • Dispute resolution
  • Mediation/facilitated discussions
  • Complaints relating to an action or lack of action by OII
  • Requests for supervisory review of a decision
  • General regulatory questions or concerns
  • Claims of retribution or unfair treatment

Program Standards of Practice

Core Standards of the Ombudsman: Independence, Informality, Impartiality, and Confidentiality (when warranted).

The OII Ombudsman abides by ethical principles and standards established by the Coalition of Federal Ombudsmen, the U.S. Ombudsman Association, and the International Ombudsman Association. These include standards for ensuring confidentiality, neutrality, and informality.

Interactions with the FDA can sometimes be confusing, daunting, and complicated. You should find interactions with the staff professionals at OII helpful and the decision made based on sound policy and regulation. Occasionally, miscommunication could occur due to a lack of feedback, disagreement between the two sides of an issue, or maybe one side has information overload. The ombudsman helps mitigate these and other concerns without the external stakeholder fearing adverse administrative or retaliatory consequences (please refer to the FDA Non-Retaliation Policy). The ombudsman advocates for fairness, efficiency, and effectiveness of OII operations.

Learn more:

Contact OII Ombudsman

Toll free 844-871-4536
OIIOmbudsman@fda.hhs.gov



Back to Top